(Q34471868)

English

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

endocannabinoids

0 references

0 references

Nicolas Flamand

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Caroline Turcotte

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

François Chouinard

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Julie S Lefebvre

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

15 April 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Journal of Leukocyte Biology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

97

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1049-1070

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The religious and medicinal uses of Cannabis in China, India and Tibet

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoid control of food intake and energy balance

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

An endocannabinoid mechanism for stress-induced analgesia.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A cannabinoid derived prototypical analgesic

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The orphan receptor GPR55 is a novel cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Pharmacological characterization of GPR55, a putative cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid modulation of peripheral autonomic and sensory neurotransmission

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The expanding field of cannabimimetic and related lipid mediators

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Astrocytes in culture produce anandamide and other acylethanolamides.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Presence and regulation of the endocannabinoid system in human dendritic cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

P2X7 receptors control 2-arachidonoylglycerol production by microglial cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

N-Acylation of ethanolamine phospholipids in canine myocardium

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Discovery and characterization of a Ca2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A biosynthetic pathway for anandamide

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A second fatty acid amide hydrolase with variable distribution among placental mammals

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Structure and function of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Oxidative metabolism of anandamide

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid-receptor expression in human leukocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoids limit excessive mast cell maturation and activation in human skin

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Human platelets express authentic CB₁ and CB₂ receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Attenuation of allergic contact dermatitis through the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoids and PPARalpha signalling.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A2A receptors in inflammation and injury: lessons learned from transgenic animals

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoids control platelet activation and limit aggregate formation under flow

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-κB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide prior to sensitization increases cell-mediated immunity in mice.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Mechanism of platelet activation induced by endocannabinoids in blood and plasma

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-α production in human monocytic cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Production and actions of the anandamide metabolite prostamide E2 in the renal medulla

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Identification of palmitoyl protein thioesterase 1 in human THP1 monocytes and macrophages and characterization of unique biochemical activities for this enzyme

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Identification of the major prostaglandin glycerol ester hydrolase in human cancer cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Occurrence of the erythroid cell specific arachidonate 15-lipoxygenase in human reticulocytes

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Inflammation and immune regulation by 12/15-lipoxygenases

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RU0115-021R

21 January 2018

Identifiers

10.1189/JLB.3RU0115-021R

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25877930%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34471868&oldid=1239820491"